The portfolio currently consists of 54 companies. Four of these are listed on AIM and 1 on LSE
; the others are displayed by sector. Since 2000
around 5 companies a year have been added to the portfolio.
If you would like to learn more about any of the companies in the current portfolio please contact us or refer to the linked company website addresses.
Med tech
| Company |
Nature |
| Eykona | 3-D imaging medical device for use in wound care |
| Organox | Portable device to preserve livers for transplantation for up to 3 days |
| Oxford Biomaterials | Variety of applications derived from knowledge of the nature of spider silk |
| Oxtox | Cost-effective technology to rapidly detect whether a person is currently 'under the influence' of specific drugs (initially cannabis) |
| Particle Therapeutics | Needleless delivery of therapeutic molecules across the skin |
Oxtex | Manufactures of anisotropic self-inflating tissue expanders |
| Company |
Nature |
| Aurox | Confocal microscope products and pathology slide scanner technology |
| Crysalin | Analysis of protein structures for proteins which cannot be easily crystallised |
| Oxford Gene Technology | Various services related to drug discovery and diagnosis(based on microarrays) |
| Oxford Nanopore Technologies | Novel DNA sequencing technology |
| Zyoxel | Commercialising microbioreactor technology to improve drug discovery and stem cell culture |
back to top
Drug Discovery
| Company |
Nature |
| Adaptimmune | T cell therapy to treat cancer and infectious diseases |
| Celleron | Developing targeted cancer medicines |
| Chronos | Developing novel proprietary drugs with specific therapeutic effects on newly discovered biological mechanisms of age related diseases |
| Immunocore | T cell receptor technology platform to treat cancer and viral diseases |
| Inhibox | Virtual screening of molecules against protein targets; broad range of computational chemistry and molecular modelling services |
| IXO Therapeutics | Research and Development of novel medicines from natural sources for the treatment of immune-medicated and inflammatory diseases |
| Oxford-Emergent Tuberculosis Consortium | Joint venture with Emergent (funding from WT and Aeras) to develop TB vaccine candidate, MVA85A |
| Oxagen | Discovery of novel drugs for inflammatory diseases (lead programme based on GPCR receptor / asthma) |
| Pharminox | Discovery of small molecule anti-cancer drugs |
| ReOx | Treatments for disease by modifying the effects of hypoxia |
| Riotech | Therapeutics for viral hepatitis |
| Sibelius | Sibelius develops its own proprietary products and assists its partners in developing their nutraceutical and cosmeceutical product lines, all with the distinct activity of extension of cellular chronological lifespan. |
Other Health Care
| Company |
Nature |
| C-med | CRO supporting services with comprehensive information and data systems |
| OBS Medical | Development of a range of patient monitoring technology and software |
| Oxitec | Effective and environment-friendly techniques to control insect pests that are damaging to public health |
| TΔS | Developing ketone bodies as medical foods to increase physical and mental performance |
Industrial applications / cleantech
| Company |
Nature |
Kepler Energy | Tidal energy power using innovative transverse horizontal axis turbine |
| Navetas | Smart electricity meter offering fully itemised energy billing |
| Oxbridge Pulsars | Data communications systems using polarization synchrotron technology |
| Oxford PhotoVoltaics | Organic solar cells for building integrated photovoltaics (BIPV) |
| Oxford RF Sensors | Designs non-contact electromagnetic sensors based on patented RF technology |
| Oxonica | Nanomaterials company with interests in fuel additives, diagnostics, materials and security |
| Oxford Imaging Detectors | Development of high performance scientific imaging detectors capable of studying structures and processes at the atomic level |
| Oxford Multi Spectral | develops and manufacturers Multi Spectral Scanners based upon a patented flatbed scanner design. |
| Yasa Motors | Break through high power-to-weight motors |
| OXEMS | Electromagnetic tagging and detection system for location of buried utilities |
| Oxyntix | Developing and commercialising new technologies in energy and process engineering |
back to top
Other technology (inc. software)
| Company |
Nature |
| Minervation | Software and web site developer - Specialises in producing and disseminating accessible, usable and reliable health information |
| NaturalMotion | Games software and games using 'on the fly' animation software |
| Oxford Ancestors | DNA-based services for personal ancestry research anywhere in the world |
| Semmle | Development of novel query languages and environments for complex hierarchical data such as the source of software systems |
| Oxford Consultants for Social Inclusion | Consultancy based on deprivation indices |
| Oxford Risk | Risk analysis services |
Listed companies
| Company |
Nature |
| Avacta | Detection and analysis of biological materials and chemicals (AIM) |
| Oxford Advanced Surfaces | Develops and commercialises advanced materials and technology solutions using novel surface modification technology (AIM) |
| Oxford Biomedica | Gene therapy and immunotherapy (LSE) |
| Oxford Catalysts Group | Catalysts for use in production of clean fuels and other renewables (AIM) |
| Summit | A range of drug discovery based on an Imino Sugar platform (AIM) |
To view companies that are no longer part of the portfolio please see the Exited Companies page.
back to top